18F-LN1 PET/CT in Urothelial Carcinomas

Launched by SICHUAN PROVINCIAL PEOPLE'S HOSPITAL · Nov 2, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging method called 18F-LN1 PET/CT to see how well it can help doctors find and evaluate urothelial carcinoma, a type of bladder cancer. The researchers will compare the results of this new method with an existing imaging technique known as 18F-FDG. The trial will involve 30 patients who have been diagnosed with or are strongly suspected of having urothelial carcinoma and have not received any treatment in the last three months.

To be eligible for the trial, participants must be at least 18 years old and have a confirmed diagnosis of urothelial carcinoma. However, individuals with certain health conditions, such as uncontrolled high blood pressure or serious heart and liver issues, cannot take part. Pregnant or breastfeeding women, as well as those who cannot lie still for about 20 minutes, will also be excluded. If you join the trial, you can expect to undergo imaging tests that will help researchers understand how well the new method works in detecting this type of cancer. This study is currently looking for participants, and your involvement could contribute to important advancements in cancer detection.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 and above
• • No gender difference
• • Patients who have been diagnosed with, or are clinically highly suspected of, urothelial carcinomas and have had no other treatment within 3 months
• Exclusion Criteria:
• • Hypertension that is difficult to control with medication, and systolic blood pressure exceeding 160mmHg
• • Complicated with chronic liver disease, myocardial infarction, stroke
• • Female patients who are pregnant (or attempting to become pregnant within six months), breastfeeding, or unwilling to use contraception
• • Abnormal cardiopulmonary function or mental state, unable to tolerate prone lying for 20 minutes